InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Lochner Daniel, Chief Financial Officer. Insider active across 2 companies, notably Oyster Point Pharma, Inc.. Cumulatively, 8 reports have been published. The latest transaction was filed on 9 January 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
019,500 shares0
Common Stock
SEC:0001209191-22-002978·
019,500 shares0
Common Stock
SEC:0001209191-22-002978:0·
€85,5538,590 shares@ €9.959637.0% of flow
Common Stock
SEC:0001209191-21-062476·
€85,5538,590 shares@ €9.959618.5% of flow
Common Stock
SEC:0001209191-21-062476:0·
€72,6867,500 shares@ €9.691431.5% of flow
Common Stock
SEC:0001209191-21-054919·
€72,6867,500 shares@ €9.691415.7% of flow
Common Stock
SEC:0001209191-21-054919:0·
€72,8737,500 shares@ €9.716431.5% of flow
Common Stock
SEC:0001209191-21-048517·
€72,8737,500 shares@ €9.716415.8% of flow
Common Stock
SEC:0001209191-21-048517:0·
8 of 8 declarations
About Lochner Daniel
Daniel Lochner is the Chief Financial Officer at Oyster Point Pharma, Inc., a biopharmaceutical company focused on developing treatments for eye diseases. He is responsible for the financial management of the company, including budgeting and financial reporting.
